Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet therapy after transcatheter aortic valve implantation
NL-OMON45158Phase 4Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin and clopidogrel in aortic valve disease (AVD) (4 cohorts), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Primary safety outcome. Started Dec 2013; status: active, not recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
aortic valve disease (AVD)
Beyond the preview
Go deeper on NL-OMON45158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45158.